<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/ct2/show/NCT02988817</url>
  </required_header>
  <id_info>
    <org_study_id>GCT1021-01</org_study_id>
    <secondary_id>2016-002243-42</secondary_id>
    <secondary_id>211258</secondary_id>
    <nct_id>NCT02988817</nct_id>
  </id_info>
  <brief_title>Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors</brief_title>
  <official_title>First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of Axl-specific Antibody-drug Conjugate (Enapotamab Vedotin, HuMax®-AXL-ADC) in Patients With Solid Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Genmab</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Genmab</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the trial is to determine the maximum tolerated dose and to establish the&#xD;
      safety profile of HuMax-AXL-ADC in a mixed population of patients with specified solid tumors&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The trial consists of two parts; a dose escalation part (phase I, first in-human (FIH)) and&#xD;
      an expansion part (phase IIa).&#xD;
&#xD;
      The dose escalation part has 2 dosing schedules: 1 dose every 3 weeks (1Q3W) dose regimen,&#xD;
      and 3 doses every 4 weeks (3Q4W) dosing regimen.&#xD;
&#xD;
      The Expansion part of the trial will further explore the recommended phase 2 dose and dosing&#xD;
      regimens of HuMax-AXL-ADC as determined in dose escalation part.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 23, 2016</start_date>
  <completion_date type="Actual">November 12, 2021</completion_date>
  <primary_completion_date type="Actual">November 12, 2021</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Dose-limiting Toxicities (DLTs) for Dose-escalation Part</measure>
    <time_frame>From Day 1 to Day 21 of first cycle for 1Q3W dosing regimen and from Day 1 to Day 28 of first cycle for 3Q4W dosing regimen</time_frame>
    <description>The DLTs were defined as Grade (G) 4 neutropenia or G4 thrombocytopenia for a minimal duration of 7 days, G3 and G4 febrile neutropenia, &gt;=G3 hemorrhage associated with &gt;=G3 thrombocytopenia, G4 anemia; Stevens Johnson syndrome, toxic epidermal necrolysis, &gt;=G3 cutaneous vasculitis; G3 neuropathy (not improved to G1 within 3 weeks following pausing of dosing) and G4 neuropathy; G3 infusion-related reactions (IRR) that did not resolve to G1 or baseline within 24 hours; G4 IRR or G4 anaphylaxis events; &gt;= G3 diarrhoea and/or vomiting persisting &gt;48 hours or G3 nausea lasting 7 days (both despite optimal medical management); or any &gt;=G3 related non-hematological AEs, which occurred during the Cycle 1 and regarded as medically important as assessed by the Data Monitoring Committee (excluding Grade 3 fatigue or non-hematological laboratory abnormalities as specified in protocol).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs)</measure>
    <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
    <description>An adverse event (AE) is any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE is defined as an AE that meets one of the following criteria: requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, is a congenital anomaly/birth defect, is medically important, results in death, or is life-threatening. In this trial, a TEAE was defined as an AE occurring or worsening between the first dose of enapotamab vedotin and 30 days after the last dose received.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Treatment-emergent Infusion-related AEs and TEAEs Related to Enapotamab Vedotin</measure>
    <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
    <description>Number of participants with treatment-emergent infusion-related AEs and TEAEs related to enapotamab vedotin is reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With &gt;= Grade 3 TEAEs as Assessed by National Cancer Institute - Common Terminology Criteria for Adverse Events (NCI-CTCAE) Version 4.03</measure>
    <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
    <description>Number of participants with TEAEs of &gt;= Grade 3 as assessed by NCI-CTCAE v4.03 is reported. The NCI-CTCAE is a descriptive terminology is used for AE reporting. The NCI-CTCAE v4.03 displays Grades 1 through 5 with unique clinical descriptions of severity for each AE, based on this general guideline: Grade 1 as mild AE, Grade 2 as moderate AE, Grade 3 as severe AE, Grade 4 as life-threatening or disabling AE, and Grade 5 as death. If a participant reported multiple severity grades for an AE, only the maximum grade was used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Grade 3 or 4 Laboratory Results</measure>
    <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
    <description>Number of participants with laboratory measurements graded as Grade 3 or 4 by NCI-CTCAE v 4.03 is reported.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area Under the Plasma Concentration-time Curve From Time 0 to Infinity (AUC0-inf) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part</measure>
    <time_frame>Predose, end of infusion (EOI), and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
    <description>The AUC0-inf of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration (AUC0-last) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part</measure>
    <time_frame>Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
    <description>The AUC0-last of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Observed Plasma Concentration (Cmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose and EOI on Days 1 and 8 of Cycles 1 and 3; and predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The Cmax of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Clearance (CL) of Conjugated Enapotamab Vedotin in Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The total CL of conjugated enapotamab vedotin in dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of Maximum Plasma Concentration (Tmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The Tmax of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Half-life Lambda-z (t1/2) of Conjugated Enapotamab Vedotin for Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The t1/2 of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of Distribution at Steady State (Vss) of Conjugated Enapotamab Vedotin for Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The Vss of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC0-inf of Free Toxin Monomethyl Auristatin E (MMAE) for 1Q3W Dose-escalation Part</measure>
    <time_frame>Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
    <description>The AUC0-inf of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC0-last of MMAE for 1Q3W Dose-escalation Part</measure>
    <time_frame>Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
    <description>The AUC0-last of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax of MMAE for Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose and EOI on Days 1 and 8 of Cycles 1 and 3; and predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The Cmax of MMAE for dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total CL of MMAE in Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The total CL of MMAE in dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax of MMAE for Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The Tmax of MMAE for dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>t1/2 of MMAE for Dose-escalation Part</measure>
    <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
    <description>The t1/2 of MMAE for dose-escalation part is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Antidrug Antibodies (ADAs) Confirmed Positive to Enapotamab Vedotin</measure>
    <time_frame>Day 1 through Day 1130 (Dose-escalation part: Predose of Day 1 of Cycles 1 to 12, end of treatment [EOT], and 30 days after last study drug; Expansion part: Predose on Day 1 of Cycles 1 to 5, then every fourth cycle until PD)</time_frame>
    <description>The ADA assessment was performed according to a tiered approach. First samples were screened for an ADA response; positively screened samples were analyzed in a confirmation method. Subsequently confirmed positive samples were analyzed for titre and the presence of neutralizing antibodies. Number of participants with ADA confirmed positive to enapotamab vedotin is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Objective Response (OR) Based on Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) As Assessed by Investigator</measure>
    <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
    <description>Radiological evaluation based on RECIST v1.1 was performed by the investigator using computed tomography (CT) scans/ magnetic resonance imaging (MRI) scans/ positron emission tomography (PET) scans. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to &lt; 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Best Cancer Antigen 125 (CA-125) Response</measure>
    <time_frame>From Screening (within 2 weeks before starting of the study treatment) through Day 1130 (maximum observed duration)</time_frame>
    <description>The best CA-125 response was evaluated in participants with ovarian cancer. A CA-125 partial response was defined as at least a 50% reduction in CA-125 levels in blood from a pretreatment sample. Participants who had a CA-125 partial response and had CA-125 level falls to within the reference range (0-35 units/mL) were classified as CA-125 complete responders. The response was confirmed and maintained for at least 28 days. The best overall response (CA-125 partial response and CA-125 complete response) is reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Response (DoR) Based on RECIST v1.1 as Assessed by Investigator for Expansion Part</measure>
    <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
    <description>The DoR was defined as the number of months from the first documentation of objective tumor response (CR or PR) to the date of first progressive disease (PD) or death. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to &lt; 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD. The PD was defined as at least 20% increase in the sum of LD of target lesions taking as reference the smallest sum of the LD recorded since the treatment started or the appearance of one or more new target and non-target lesions and/or unequivocal progression of existing non-target lesions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression Free Survival (PFS) as Assessed by Investigator</measure>
    <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
    <description>The PFS was defined as the number of months from the date of first study drug administration to first PD or death. The PD was defined as at least 20% increase in the sum of longest diameters of target lesions taking as reference the smallest sum of the longest diameters recorded since the treatment started or the appearance of one or more new lesions. The PFS was estimated using Kaplan-Meier method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival (OS)</measure>
    <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
    <description>Overall survival was defined as the number of months from date of first study drug administration to death. The OS was estimated using Kaplan-Meier method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in AXL Expression (Total Tumor H-score) From Baseline to EOT Visit for Expansion Part</measure>
    <time_frame>Baseline (Study Days -21 to 1) and EOT visit (Day 1100)</time_frame>
    <description>Change in AXL expression (total humor H-score in membrane or cytoplasm) from Baseline to EOT visit for the expansion part is reported. The H-score captures both the intensity and proportion of AXL positive tumor cells and was defined by the formula: H-score = (1 × % 1+ tumor cells) + (2 × % 2+ tumor cells) + (3 × % 3+ tumor cells); where '1+' indicates weak staining intensity, '2+' indicates medium staining intensity, and '3+' indicates strong staining intensity. The H-score values ranges from 0 to 300. Lower H-scores represent lower AXL expression in the tumor sample, while higher scores represent stronger AXL expression in the tumor samples.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">306</enrollment>
  <condition>Ovarian Cancer</condition>
  <condition>Cervical Cancer</condition>
  <condition>Endometrial Cancer</condition>
  <condition>Non Small Cell Lung Cancer (NSCLC)</condition>
  <condition>Thyroid Cancer</condition>
  <condition>Melanoma</condition>
  <condition>Sarcoma</condition>
  <condition>Solid Tumors</condition>
  <arm_group>
    <arm_group_label>Enapotamab vedotin (HuMax-AXL-ADC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in all cohorts of the trial (both in escalation and expansion phase) will be administered enapotamab vedotin (HuMax-AXL-ADC) intravenously (IV).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Enapotamab vedotin (HuMax-AXL-ADC)</intervention_name>
    <description>Enapotamab vedotin (HuMax-AXL-ADC) will be administered intravenously.</description>
    <arm_group_label>Enapotamab vedotin (HuMax-AXL-ADC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. For the dose escalation part: Patients with selected, relapsed or refractory solid&#xD;
             tumors who have failed available standard therapy or who are not candidates for&#xD;
             standard therapy. For the expansion part: Patients with advanced and/or metastatic&#xD;
             solid tumors who are not candidates for standard therapy&#xD;
&#xD;
          2. Patients must have measurable disease according to Response Evaluation Criteria In&#xD;
             Solid Tumors (RECIST).&#xD;
&#xD;
          3. For the expansion patients must provide a tumor tissue sample from archival tissue or&#xD;
             fresh biopsy at enrolment&#xD;
&#xD;
          4. Age ≥ 18 years.&#xD;
&#xD;
          5. Acceptable renal function&#xD;
&#xD;
          6. Acceptable liver function&#xD;
&#xD;
          7. Acceptable hematological status&#xD;
&#xD;
          8. Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1.&#xD;
&#xD;
          9. Life expectancy of at least three months.&#xD;
&#xD;
         10. Patients, both females and males, of childbearing/reproductive potential must agree to&#xD;
             use adequate contraception while included in the trial and for six months after the&#xD;
             last infusion of HuMax-AXL-ADC&#xD;
&#xD;
         11. Patients must provide a signed informed consent form before any trial relates&#xD;
             activities are carried out.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Acute deep vein thrombosis or clinically relevant pulmonary embolism, not stable for&#xD;
             at least 4 weeks prior to first IMP administration.&#xD;
&#xD;
          2. Have clinically significant cardiac disease&#xD;
&#xD;
          3. Known congestive heart failure and/ or a known decreased cardiac ejection fraction of&#xD;
             &lt; 45%. A baseline QT interval as corrected by Fridericia's formula (QTcF) &gt; 480 msec,&#xD;
             a complete left bundle branch block (defined as a QRS interval ≥ 120 msec in left&#xD;
             bundle branch block form) or an incomplete left bundle branch block.&#xD;
&#xD;
          4. Uncontrolled hypertension&#xD;
&#xD;
          5. Have received granulocyte colony stimulating factor (G-CSF) or granulocyte/macrophage&#xD;
             colony stimulating factor support 3 weeks prior to first IMP administration.&#xD;
&#xD;
          6. Have received a cumulative dose of corticosteroid &gt; 150 mg prednisone (or equivalent&#xD;
             doses of corticosteroids) within two weeks before the first Investigational Medicinal&#xD;
             Product (IMP) administration.&#xD;
&#xD;
          7. History of ≥ grade 3 allergic reactions to monoclonal antibody therapy as well as&#xD;
             known or suspected allergy or intolerance to any agent given in the course of this&#xD;
             trial.&#xD;
&#xD;
          8. Major surgery within four weeks before first IMP administration.&#xD;
&#xD;
          9. Any history of intracerebral arteriovenous malformation, cerebral aneurysm, brain&#xD;
             metastases or stroke.&#xD;
&#xD;
         10. Any anticancer therapy including; small molecules, immunotherapy, chemotherapy&#xD;
             monoclonal antibodies or any other experimental drug within five half-lives but&#xD;
             maximum four weeks before first infusion. Accepted exceptions are bisphosphonates,&#xD;
             denosumab and gonadotropin-releasing hormone agonist or antagonist.&#xD;
&#xD;
         11. Prior therapy with a conjugated or unconjugated auristatin derivative/vinca-binding&#xD;
             site targeting payload.&#xD;
&#xD;
         12. Radiotherapy within 14 days prior to first IMP administration.&#xD;
&#xD;
         13. Known past or current malignancy other than inclusion diagnosis, except for:&#xD;
&#xD;
               -  Cervical carcinoma of Stage 1B or less.&#xD;
&#xD;
               -  Non-invasive basal cell or squamous cell skin carcinoma.&#xD;
&#xD;
               -  Non-invasive, superficial bladder cancer.&#xD;
&#xD;
               -  Prostate cancer with a current prostate specific antigen (PSA) level &lt; 0.1 ng/mL.&#xD;
&#xD;
               -  Breast cancer in BRCA1 or BRCA2 positive ovarian cancer patients.&#xD;
&#xD;
               -  Any curable cancer with a complete response (CR) of &gt; 2 years duration.&#xD;
&#xD;
         14. Melanoma patients with an lactate dehydrogenase (LDH) ≥ 3 x upper limit normal (ULN).&#xD;
&#xD;
         15. Ongoing significant, uncontrolled medical condition including:&#xD;
&#xD;
             o Serious, non-healing wound, skin ulcer (of any grade), or bone fracture.&#xD;
&#xD;
         16. Grade 2 or higher peripheral neuropathy.&#xD;
&#xD;
         17. Clinically significant active viral, bacterial or fungal infection&#xD;
&#xD;
         18. Known human immunodeficiency virus seropositivity.&#xD;
&#xD;
         19. Known positive serology for hepatitis B (unless due to vaccination or passive&#xD;
             immunization due to immunoglobulin therapy)&#xD;
&#xD;
         20. Known positive serology for hepatitis C (unless due to immunoglobulin therapy)&#xD;
&#xD;
         21. Substance abuse, medical, psychological or social conditions that may interfere with&#xD;
             the patient's participation in the trial or evaluation of the trial result&#xD;
&#xD;
         22. History of organ allograft (except for corneal transplant) or autologous or allogeneic&#xD;
             bone marrow transplant, or stem cell rescue within 3 months prior to the first dose of&#xD;
             IMP&#xD;
&#xD;
         23. Body weight &lt; 40 kg&#xD;
&#xD;
         24. Women who are pregnant or breast feeding.&#xD;
&#xD;
         25. Pulmonary hemorrhage or hemoptysis &gt; 2.5 ml blood within 6 weeks unless cause has been&#xD;
             addressed and is medically resolved.&#xD;
&#xD;
         26. History of acute pneumonitis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ignace Vergote, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic - Phoenix</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University, Smilow Cancer Center at Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University School of Medicine, Winship Cancer Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dana-Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Comprehensive Cancer Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roswell Park Comprehensive Cancer Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laura and Isaac Perlmutter Cancer Center at NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herbert Irving Comprehensive Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke Cancer Institute</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mary Crowley Cancer Research Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Huntsman Cancer Institute</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Carbone Cancer Center</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuizen Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Flemish Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut Roi Albert II - Cliniques Universitaires Saint Luc</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel - Oncologisch Centrum</name>
      <address>
        <city>Jette</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medische oncologie, Oncologisch Centrum - AZ Groeninge</name>
      <address>
        <city>Kortrijk</city>
        <zip>8500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>U.Z. Leuven Gasthuisberg, Department of General Medical Oncology</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Liège, Medical Oncology et. Domaine Universitaire du Sart Tilman</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet, Copenhagen University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>DK-2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital</name>
      <address>
        <city>Amsterdam</city>
        <zip>1066</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Centre</name>
      <address>
        <city>Leiden</city>
        <zip>2333</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erasmus MC, Medical Oncology</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMC Utrecht Cancer Center</name>
      <address>
        <city>Utrecht</city>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Unversitario Vall D'hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oncologia Mèdica/ Medical Oncology Department Institut Catalá d'Oncologia (ICO)</name>
      <address>
        <city>Barcelona</city>
        <zip>08909</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Girona</name>
      <address>
        <city>Girona</city>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 Octubre Servicio de Oncologia Medica</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <zip>29016</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Lozano Blesa, Aragón Health Research Institute (IIS Aragón)</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College London Hospitals</name>
      <address>
        <city>London</city>
        <zip>NW1 2PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Christie NHS Foundation Trust Clinical Trials Unit</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Bobby Robson Clinical Trials Unit at the Northern Centre for Cancer Care, Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Royal Marsden Hospital</name>
      <address>
        <city>Sutton</city>
        <zip>SM2 5PT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2023</verification_date>
  <study_first_submitted>December 1, 2016</study_first_submitted>
  <study_first_submitted_qc>December 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2016</study_first_posted>
  <results_first_submitted>November 7, 2022</results_first_submitted>
  <results_first_submitted_qc>December 12, 2022</results_first_submitted_qc>
  <results_first_posted type="Actual">January 5, 2023</results_first_posted>
  <last_update_submitted>July 31, 2023</last_update_submitted>
  <last_update_submitted_qc>July 31, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">August 1, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 30, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT02988817/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 30, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/17/NCT02988817/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P2">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P3">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment..</description>
        </group>
        <group group_id="P4">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment..</description>
        </group>
        <group group_id="P5">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P6">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P7">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P8">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="P9">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="P10">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="P11">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="P12">
          <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing epidermal growth factor receptor (EGFR) mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors, received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P13">
          <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P14">
          <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P15">
          <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P16">
          <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="P17">
          <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P18">
          <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or anaplastic lymphoma kinase (ALK) rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P19">
          <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="P20">
          <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="11"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="6"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="22"/>
                <participants group_id="P13" count="16"/>
                <participants group_id="P14" count="25"/>
                <participants group_id="P15" count="25"/>
                <participants group_id="P16" count="44"/>
                <participants group_id="P17" count="25"/>
                <participants group_id="P18" count="55"/>
                <participants group_id="P19" count="21"/>
                <participants group_id="P20" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="10"/>
                <participants group_id="P6" count="11"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="6"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="22"/>
                <participants group_id="P13" count="16"/>
                <participants group_id="P14" count="25"/>
                <participants group_id="P15" count="25"/>
                <participants group_id="P16" count="44"/>
                <participants group_id="P17" count="25"/>
                <participants group_id="P18" count="55"/>
                <participants group_id="P19" count="21"/>
                <participants group_id="P20" count="26"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="12"/>
                <participants group_id="P13" count="6"/>
                <participants group_id="P14" count="6"/>
                <participants group_id="P15" count="4"/>
                <participants group_id="P16" count="5"/>
                <participants group_id="P17" count="4"/>
                <participants group_id="P18" count="11"/>
                <participants group_id="P19" count="4"/>
                <participants group_id="P20" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="6"/>
                <participants group_id="P6" count="10"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="5"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="8"/>
                <participants group_id="P13" count="9"/>
                <participants group_id="P14" count="17"/>
                <participants group_id="P15" count="18"/>
                <participants group_id="P16" count="30"/>
                <participants group_id="P17" count="17"/>
                <participants group_id="P18" count="38"/>
                <participants group_id="P19" count="14"/>
                <participants group_id="P20" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Sponsor decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="2"/>
                <participants group_id="P15" count="2"/>
                <participants group_id="P16" count="6"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="3"/>
                <participants group_id="P19" count="2"/>
                <participants group_id="P20" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were analyzed according to the assigned treatment/dose (planned dose level and schedule).</population>
      <group_list>
        <group group_id="B1">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B2">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B3">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B4">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B5">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B6">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B7">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B8">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="B9">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="B10">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="B11">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="B12">
          <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or classical metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B13">
          <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B14">
          <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B15">
          <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B16">
          <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="B17">
          <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B18">
          <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B19">
          <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="B20">
          <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="B21">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="3"/>
            <count group_id="B4" value="3"/>
            <count group_id="B5" value="10"/>
            <count group_id="B6" value="11"/>
            <count group_id="B7" value="3"/>
            <count group_id="B8" value="3"/>
            <count group_id="B9" value="3"/>
            <count group_id="B10" value="6"/>
            <count group_id="B11" value="3"/>
            <count group_id="B12" value="22"/>
            <count group_id="B13" value="16"/>
            <count group_id="B14" value="25"/>
            <count group_id="B15" value="25"/>
            <count group_id="B16" value="44"/>
            <count group_id="B17" value="25"/>
            <count group_id="B18" value="55"/>
            <count group_id="B19" value="21"/>
            <count group_id="B20" value="26"/>
            <count group_id="B21" value="306"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>&gt;=18 to &lt;65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="4"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="12"/>
                    <measurement group_id="B13" value="14"/>
                    <measurement group_id="B14" value="13"/>
                    <measurement group_id="B15" value="15"/>
                    <measurement group_id="B16" value="23"/>
                    <measurement group_id="B17" value="16"/>
                    <measurement group_id="B18" value="24"/>
                    <measurement group_id="B19" value="15"/>
                    <measurement group_id="B20" value="17"/>
                    <measurement group_id="B21" value="180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="2"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="10"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="12"/>
                    <measurement group_id="B15" value="10"/>
                    <measurement group_id="B16" value="21"/>
                    <measurement group_id="B17" value="9"/>
                    <measurement group_id="B18" value="31"/>
                    <measurement group_id="B19" value="6"/>
                    <measurement group_id="B20" value="9"/>
                    <measurement group_id="B21" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="13"/>
                    <measurement group_id="B13" value="8"/>
                    <measurement group_id="B14" value="7"/>
                    <measurement group_id="B15" value="14"/>
                    <measurement group_id="B16" value="17"/>
                    <measurement group_id="B17" value="25"/>
                    <measurement group_id="B18" value="25"/>
                    <measurement group_id="B19" value="11"/>
                    <measurement group_id="B20" value="13"/>
                    <measurement group_id="B21" value="174"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="9"/>
                    <measurement group_id="B13" value="8"/>
                    <measurement group_id="B14" value="18"/>
                    <measurement group_id="B15" value="11"/>
                    <measurement group_id="B16" value="27"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="30"/>
                    <measurement group_id="B19" value="10"/>
                    <measurement group_id="B20" value="13"/>
                    <measurement group_id="B21" value="132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="11"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="3"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="22"/>
                    <measurement group_id="B13" value="16"/>
                    <measurement group_id="B14" value="24"/>
                    <measurement group_id="B15" value="24"/>
                    <measurement group_id="B16" value="43"/>
                    <measurement group_id="B17" value="23"/>
                    <measurement group_id="B18" value="53"/>
                    <measurement group_id="B19" value="21"/>
                    <measurement group_id="B20" value="25"/>
                    <measurement group_id="B21" value="297"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="3"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="3"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="10"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="3"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="6"/>
                    <measurement group_id="B11" value="3"/>
                    <measurement group_id="B12" value="18"/>
                    <measurement group_id="B13" value="12"/>
                    <measurement group_id="B14" value="21"/>
                    <measurement group_id="B15" value="24"/>
                    <measurement group_id="B16" value="37"/>
                    <measurement group_id="B17" value="20"/>
                    <measurement group_id="B18" value="50"/>
                    <measurement group_id="B19" value="20"/>
                    <measurement group_id="B20" value="23"/>
                    <measurement group_id="B21" value="269"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="4"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="4"/>
                    <measurement group_id="B18" value="3"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="2"/>
                    <measurement group_id="B21" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Dose-limiting Toxicities (DLTs) for Dose-escalation Part</title>
        <description>The DLTs were defined as Grade (G) 4 neutropenia or G4 thrombocytopenia for a minimal duration of 7 days, G3 and G4 febrile neutropenia, &gt;=G3 hemorrhage associated with &gt;=G3 thrombocytopenia, G4 anemia; Stevens Johnson syndrome, toxic epidermal necrolysis, &gt;=G3 cutaneous vasculitis; G3 neuropathy (not improved to G1 within 3 weeks following pausing of dosing) and G4 neuropathy; G3 infusion-related reactions (IRR) that did not resolve to G1 or baseline within 24 hours; G4 IRR or G4 anaphylaxis events; &gt;= G3 diarrhoea and/or vomiting persisting &gt;48 hours or G3 nausea lasting 7 days (both despite optimal medical management); or any &gt;=G3 related non-hematological AEs, which occurred during the Cycle 1 and regarded as medically important as assessed by the Data Monitoring Committee (excluding Grade 3 fatigue or non-hematological laboratory abnormalities as specified in protocol).</description>
        <time_frame>From Day 1 to Day 21 of first cycle for 1Q3W dosing regimen and from Day 1 to Day 28 of first cycle for 3Q4W dosing regimen</time_frame>
        <population>Dose-determining set included all participants from the Safety Set (participants who received at least 1 dose of enapotamab vedotin, had at least one valid post-baseline safety assessment, and were classified according to first dose received) who either met the minimum exposure criterion and completed the DLT observation period, or who experienced a DLT during Cycle 1.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Dose-limiting Toxicities (DLTs) for Dose-escalation Part</title>
          <description>The DLTs were defined as Grade (G) 4 neutropenia or G4 thrombocytopenia for a minimal duration of 7 days, G3 and G4 febrile neutropenia, &gt;=G3 hemorrhage associated with &gt;=G3 thrombocytopenia, G4 anemia; Stevens Johnson syndrome, toxic epidermal necrolysis, &gt;=G3 cutaneous vasculitis; G3 neuropathy (not improved to G1 within 3 weeks following pausing of dosing) and G4 neuropathy; G3 infusion-related reactions (IRR) that did not resolve to G1 or baseline within 24 hours; G4 IRR or G4 anaphylaxis events; &gt;= G3 diarrhoea and/or vomiting persisting &gt;48 hours or G3 nausea lasting 7 days (both despite optimal medical management); or any &gt;=G3 related non-hematological AEs, which occurred during the Cycle 1 and regarded as medically important as assessed by the Data Monitoring Committee (excluding Grade 3 fatigue or non-hematological laboratory abnormalities as specified in protocol).</description>
          <population>Dose-determining set included all participants from the Safety Set (participants who received at least 1 dose of enapotamab vedotin, had at least one valid post-baseline safety assessment, and were classified according to first dose received) who either met the minimum exposure criterion and completed the DLT observation period, or who experienced a DLT during Cycle 1.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs)</title>
        <description>An adverse event (AE) is any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE is defined as an AE that meets one of the following criteria: requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, is a congenital anomaly/birth defect, is medically important, results in death, or is life-threatening. In this trial, a TEAE was defined as an AE occurring or worsening between the first dose of enapotamab vedotin and 30 days after the last dose received.</description>
        <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
        <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs)</title>
          <description>An adverse event (AE) is any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE is defined as an AE that meets one of the following criteria: requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, is a congenital anomaly/birth defect, is medically important, results in death, or is life-threatening. In this trial, a TEAE was defined as an AE occurring or worsening between the first dose of enapotamab vedotin and 30 days after the last dose received.</description>
          <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="56"/>
                <count group_id="O19" value="20"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="11"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="22"/>
                    <measurement group_id="O13" value="16"/>
                    <measurement group_id="O14" value="25"/>
                    <measurement group_id="O15" value="25"/>
                    <measurement group_id="O16" value="44"/>
                    <measurement group_id="O17" value="25"/>
                    <measurement group_id="O18" value="56"/>
                    <measurement group_id="O19" value="20"/>
                    <measurement group_id="O20" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any TESAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="6"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="5"/>
                    <measurement group_id="O14" value="16"/>
                    <measurement group_id="O15" value="10"/>
                    <measurement group_id="O16" value="16"/>
                    <measurement group_id="O17" value="12"/>
                    <measurement group_id="O18" value="33"/>
                    <measurement group_id="O19" value="7"/>
                    <measurement group_id="O20" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Treatment-emergent Infusion-related AEs and TEAEs Related to Enapotamab Vedotin</title>
        <description>Number of participants with treatment-emergent infusion-related AEs and TEAEs related to enapotamab vedotin is reported.</description>
        <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
        <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Treatment-emergent Infusion-related AEs and TEAEs Related to Enapotamab Vedotin</title>
          <description>Number of participants with treatment-emergent infusion-related AEs and TEAEs related to enapotamab vedotin is reported.</description>
          <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="56"/>
                <count group_id="O19" value="20"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Treatment emergent infusion-related AEs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="2"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="2"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TEAEs related to enapotamab vedotin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                    <measurement group_id="O5" value="10"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="3"/>
                    <measurement group_id="O9" value="3"/>
                    <measurement group_id="O10" value="6"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="21"/>
                    <measurement group_id="O13" value="15"/>
                    <measurement group_id="O14" value="24"/>
                    <measurement group_id="O15" value="24"/>
                    <measurement group_id="O16" value="38"/>
                    <measurement group_id="O17" value="23"/>
                    <measurement group_id="O18" value="52"/>
                    <measurement group_id="O19" value="16"/>
                    <measurement group_id="O20" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With &gt;= Grade 3 TEAEs as Assessed by National Cancer Institute - Common Terminology Criteria for Adverse Events (NCI-CTCAE) Version 4.03</title>
        <description>Number of participants with TEAEs of &gt;= Grade 3 as assessed by NCI-CTCAE v4.03 is reported. The NCI-CTCAE is a descriptive terminology is used for AE reporting. The NCI-CTCAE v4.03 displays Grades 1 through 5 with unique clinical descriptions of severity for each AE, based on this general guideline: Grade 1 as mild AE, Grade 2 as moderate AE, Grade 3 as severe AE, Grade 4 as life-threatening or disabling AE, and Grade 5 as death. If a participant reported multiple severity grades for an AE, only the maximum grade was used.</description>
        <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
        <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With &gt;= Grade 3 TEAEs as Assessed by National Cancer Institute - Common Terminology Criteria for Adverse Events (NCI-CTCAE) Version 4.03</title>
          <description>Number of participants with TEAEs of &gt;= Grade 3 as assessed by NCI-CTCAE v4.03 is reported. The NCI-CTCAE is a descriptive terminology is used for AE reporting. The NCI-CTCAE v4.03 displays Grades 1 through 5 with unique clinical descriptions of severity for each AE, based on this general guideline: Grade 1 as mild AE, Grade 2 as moderate AE, Grade 3 as severe AE, Grade 4 as life-threatening or disabling AE, and Grade 5 as death. If a participant reported multiple severity grades for an AE, only the maximum grade was used.</description>
          <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="56"/>
                <count group_id="O19" value="20"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="9"/>
                    <measurement group_id="O7" value="3"/>
                    <measurement group_id="O8" value="1"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="3"/>
                    <measurement group_id="O11" value="3"/>
                    <measurement group_id="O12" value="15"/>
                    <measurement group_id="O13" value="6"/>
                    <measurement group_id="O14" value="18"/>
                    <measurement group_id="O15" value="16"/>
                    <measurement group_id="O16" value="21"/>
                    <measurement group_id="O17" value="15"/>
                    <measurement group_id="O18" value="40"/>
                    <measurement group_id="O19" value="14"/>
                    <measurement group_id="O20" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Plasma Concentration-time Curve From Time 0 to Infinity (AUC0-inf) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part</title>
        <description>The AUC0-inf of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
        <time_frame>Predose, end of infusion (EOI), and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
        <population>Pharmacokinetic (PK) analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Plasma Concentration-time Curve From Time 0 to Infinity (AUC0-inf) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part</title>
          <description>The AUC0-inf of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
          <population>Pharmacokinetic (PK) analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>day*ug/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.143" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="13.233" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="18.353" spread="8.6"/>
                    <measurement group_id="O4" value="40.921" spread="27.7"/>
                    <measurement group_id="O5" value="64.140" spread="13.2"/>
                    <measurement group_id="O6" value="67.998" spread="32.2"/>
                    <measurement group_id="O7" value="76.264" spread="31.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.780" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="10.892" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="18.664" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="39.589" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="56.842" spread="23.8"/>
                    <measurement group_id="O6" value="61.161" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration (AUC0-last) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part</title>
        <description>The AUC0-last of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
        <time_frame>Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration (AUC0-last) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part</title>
          <description>The AUC0-last of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>day*ug/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.509" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="10.369" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="16.004" spread="18.5"/>
                    <measurement group_id="O4" value="36.526" spread="29.7"/>
                    <measurement group_id="O5" value="58.410" spread="11.6"/>
                    <measurement group_id="O6" value="62.563" spread="29.7"/>
                    <measurement group_id="O7" value="71.196" spread="32.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.306" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="9.157" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="15.047" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="36.333" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="51.541" spread="21.4"/>
                    <measurement group_id="O6" value="57.759" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maximum Observed Plasma Concentration (Cmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
        <description>The Cmax of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose and EOI on Days 1 and 8 of Cycles 1 and 3; and predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Observed Plasma Concentration (Cmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
          <description>The Cmax of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>ug/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="2"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.250" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="12.600" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="16.615" spread="16.7"/>
                    <measurement group_id="O4" value="33.005" spread="9.4"/>
                    <measurement group_id="O5" value="39.647" spread="11.4"/>
                    <measurement group_id="O6" value="43.377" spread="25.6"/>
                    <measurement group_id="O7" value="48.548" spread="33.0"/>
                    <measurement group_id="O8" value="10.127" spread="40.2"/>
                    <measurement group_id="O9" value="14.307" spread="31.6"/>
                    <measurement group_id="O10" value="18.040" spread="12.0"/>
                    <measurement group_id="O11" value="17.928" spread="22.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="14.201" spread="11.9"/>
                    <measurement group_id="O9" value="16.765" spread="36.3"/>
                    <measurement group_id="O10" value="18.698" spread="8.1"/>
                    <measurement group_id="O11" value="18.958" spread="19.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="13.172" spread="8.0"/>
                    <measurement group_id="O9" value="16.166" spread="37.2"/>
                    <measurement group_id="O10" value="16.991" spread="7.8"/>
                    <measurement group_id="O11" value="18.500" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.870" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="11.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="16.200" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="32.400" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="35.890" spread="17.9"/>
                    <measurement group_id="O6" value="38.928" spread="9.0"/>
                    <measurement group_id="O9" value="22.400" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O10" value="21.800" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="21.200" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="24.100" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O10" value="22.800" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Clearance (CL) of Conjugated Enapotamab Vedotin in Dose-escalation Part</title>
        <description>The total CL of conjugated enapotamab vedotin in dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Clearance (CL) of Conjugated Enapotamab Vedotin in Dose-escalation Part</title>
          <description>The total CL of conjugated enapotamab vedotin in dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>L/day</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.053" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="3.446" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="3.538" spread="21.8"/>
                    <measurement group_id="O4" value="2.307" spread="28.3"/>
                    <measurement group_id="O5" value="2.202" spread="22.2"/>
                    <measurement group_id="O6" value="2.205" spread="25.4"/>
                    <measurement group_id="O7" value="1.783" spread="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="3.679" spread="9.4"/>
                    <measurement group_id="O9" value="3.084" spread="93.8"/>
                    <measurement group_id="O10" value="3.402" spread="31.3"/>
                    <measurement group_id="O11" value="2.629" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.360" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="4.187" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="3.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="2.160" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="2.285" spread="27.1"/>
                    <measurement group_id="O6" value="2.539" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="2.281" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O10" value="3.412" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time of Maximum Plasma Concentration (Tmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
        <description>The Tmax of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Time of Maximum Plasma Concentration (Tmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
          <description>The Tmax of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>Day</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" lower_limit="0.06" upper_limit="0.06"/>
                    <measurement group_id="O2" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O3" value="0.036" lower_limit="0.03" upper_limit="0.04"/>
                    <measurement group_id="O4" value="0.033" lower_limit="0.03" upper_limit="0.04"/>
                    <measurement group_id="O5" value="0.032" lower_limit="0.02" upper_limit="0.09"/>
                    <measurement group_id="O6" value="0.032" lower_limit="0.02" upper_limit="0.04"/>
                    <measurement group_id="O7" value="0.03" lower_limit="0.02" upper_limit="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="14.010" lower_limit="13.96" upper_limit="14.88"/>
                    <measurement group_id="O9" value="14.058" lower_limit="13.98" upper_limit="14.08"/>
                    <measurement group_id="O10" value="14.083" lower_limit="14.00" upper_limit="14.19"/>
                    <measurement group_id="O11" value="13.98" lower_limit="13.98" upper_limit="13.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" lower_limit="0.04" upper_limit="0.04"/>
                    <measurement group_id="O2" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O3" value="0.04" lower_limit="0.04" upper_limit="0.04"/>
                    <measurement group_id="O4" value="0.030" lower_limit="0.03" upper_limit="0.03"/>
                    <measurement group_id="O5" value="0.036" lower_limit="0.02" upper_limit="0.05"/>
                    <measurement group_id="O6" value="0.042" lower_limit="0.03" upper_limit="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="14.02" lower_limit="14.02" upper_limit="14.02"/>
                    <measurement group_id="O10" value="13.98" lower_limit="13.98" upper_limit="13.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Half-life Lambda-z (t1/2) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
        <description>The t1/2 of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Half-life Lambda-z (t1/2) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
          <description>The t1/2 of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>Day</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.87" lower_limit="0.87" upper_limit="0.87"/>
                    <measurement group_id="O2" value="1.49" lower_limit="1.49" upper_limit="1.49"/>
                    <measurement group_id="O3" value="1.362" lower_limit="1.02" upper_limit="1.39"/>
                    <measurement group_id="O4" value="1.384" lower_limit="1.19" upper_limit="1.65"/>
                    <measurement group_id="O5" value="2.004" lower_limit="1.67" upper_limit="2.53"/>
                    <measurement group_id="O6" value="1.810" lower_limit="1.53" upper_limit="2.74"/>
                    <measurement group_id="O7" value="2.153" lower_limit="1.99" upper_limit="2.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="1.097" lower_limit="0.66" upper_limit="1.56"/>
                    <measurement group_id="O9" value="1.398" lower_limit="0.91" upper_limit="1.81"/>
                    <measurement group_id="O10" value="1.423" lower_limit="0.77" upper_limit="1.96"/>
                    <measurement group_id="O11" value="2.05" lower_limit="2.05" upper_limit="2.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.78" lower_limit="0.78" upper_limit="0.78"/>
                    <measurement group_id="O2" value="1.07" lower_limit="1.07" upper_limit="1.07"/>
                    <measurement group_id="O3" value="1.130" lower_limit="1.13" upper_limit="1.13"/>
                    <measurement group_id="O4" value="1.68" lower_limit="1.68" upper_limit="1.68"/>
                    <measurement group_id="O5" value="2.117" lower_limit="1.55" upper_limit="2.90"/>
                    <measurement group_id="O6" value="2.035" lower_limit="1.38" upper_limit="2.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="1.51" lower_limit="1.51" upper_limit="1.51"/>
                    <measurement group_id="O10" value="1.44" lower_limit="1.44" upper_limit="1.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Volume of Distribution at Steady State (Vss) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
        <description>The Vss of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Volume of Distribution at Steady State (Vss) of Conjugated Enapotamab Vedotin for Dose-escalation Part</title>
          <description>The Vss of conjugated enapotamab vedotin for dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>L/day</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.909" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="6.544" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="5.873" spread="9.8"/>
                    <measurement group_id="O4" value="4.208" spread="12.5"/>
                    <measurement group_id="O5" value="6.028" spread="18.4"/>
                    <measurement group_id="O6" value="5.489" spread="24.2"/>
                    <measurement group_id="O7" value="5.038" spread="27.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="57.736" spread="10.0"/>
                    <measurement group_id="O9" value="48.001" spread="91.1"/>
                    <measurement group_id="O10" value="53.436" spread="28.0"/>
                    <measurement group_id="O11" value="42.708" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.755" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="6.288" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="4.870" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="4.534" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="6.072" spread="24.2"/>
                    <measurement group_id="O6" value="6.656" spread="22.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="36.476" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O10" value="53.085" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC0-inf of Free Toxin Monomethyl Auristatin E (MMAE) for 1Q3W Dose-escalation Part</title>
        <description>The AUC0-inf of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
        <time_frame>Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC0-inf of Free Toxin Monomethyl Auristatin E (MMAE) for 1Q3W Dose-escalation Part</title>
          <description>The AUC0-inf of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>day*pg/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3832.48" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="6144.11" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="13673.7" spread="110.4"/>
                    <measurement group_id="O4" value="26549.1" spread="82.9"/>
                    <measurement group_id="O5" value="33494.5" spread="47.1"/>
                    <measurement group_id="O6" value="50459.6" spread="117.0"/>
                    <measurement group_id="O7" value="48626.4" spread="95.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3248.46" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="7452.05" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="4338.20" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="47093.9" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="30512.0" spread="47.8"/>
                    <measurement group_id="O6" value="34188.6" spread="46.6"/>
                    <measurement group_id="O7" value="16754.5" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC0-last of MMAE for 1Q3W Dose-escalation Part</title>
        <description>The AUC0-last of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
        <time_frame>Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC0-last of MMAE for 1Q3W Dose-escalation Part</title>
          <description>The AUC0-last of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>day*pg/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3364.64" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="5980.86" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="13194.4" spread="110.4"/>
                    <measurement group_id="O4" value="25549.3" spread="80.8"/>
                    <measurement group_id="O5" value="31854.7" spread="46.4"/>
                    <measurement group_id="O6" value="34659.4" spread="81.2"/>
                    <measurement group_id="O7" value="38963.5" spread="65.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2642.23" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="7263.16" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="4156.66" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="44553.3" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="28890.0" spread="47.4"/>
                    <measurement group_id="O6" value="31429.9" spread="43.2"/>
                    <measurement group_id="O7" value="16354.3" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax of MMAE for Dose-escalation Part</title>
        <description>The Cmax of MMAE for dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose and EOI on Days 1 and 8 of Cycles 1 and 3; and predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax of MMAE for Dose-escalation Part</title>
          <description>The Cmax of MMAE for dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>pg/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="700.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="947.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="1874.13" spread="5"/>
                    <measurement group_id="O4" value="4036.47" spread="81.8"/>
                    <measurement group_id="O5" value="4265.60" spread="46.1"/>
                    <measurement group_id="O6" value="5154.58" spread="61.9"/>
                    <measurement group_id="O7" value="5617.89" spread="34.7"/>
                    <measurement group_id="O8" value="161.140" spread="75.0"/>
                    <measurement group_id="O9" value="175.315" spread="159.4"/>
                    <measurement group_id="O10" value="303.977" spread="45.3"/>
                    <measurement group_id="O11" value="244.623" spread="48.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="738.227" spread="28.2"/>
                    <measurement group_id="O9" value="766.467" spread="91.4"/>
                    <measurement group_id="O10" value="1982.67" spread="58.1"/>
                    <measurement group_id="O11" value="1553.93" spread="86.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="1715.54" spread="42.8"/>
                    <measurement group_id="O9" value="2525.75" spread="54.7"/>
                    <measurement group_id="O10" value="4379.50" spread="58.2"/>
                    <measurement group_id="O11" value="3720.00" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="631.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="1200.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="628.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="6500.00" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="3964.40" spread="49.4"/>
                    <measurement group_id="O6" value="4127.31" spread="39.3"/>
                    <measurement group_id="O7" value="2180.00" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O9" value="442.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O10" value="558.000" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 8</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="1060.00" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="2960.00" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O10" value="5190.00" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total CL of MMAE in Dose-escalation Part</title>
        <description>The total CL of MMAE in dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Total CL of MMAE in Dose-escalation Part</title>
          <description>The total CL of MMAE in dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>L/day</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6497.09" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="7421.74" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="4748.64" spread="87.2"/>
                    <measurement group_id="O4" value="3555.78" spread="90.6"/>
                    <measurement group_id="O5" value="4216.71" spread="42.0"/>
                    <measurement group_id="O6" value="2971.09" spread="107.2"/>
                    <measurement group_id="O7" value="2813.05" spread="35.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="4819.44" spread="25.8"/>
                    <measurement group_id="O9" value="4666.23" spread="35.5"/>
                    <measurement group_id="O10" value="2847.55" spread="46.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7757.51" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O2" value="6119.12" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O3" value="12908.6" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O4" value="1815.52" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O5" value="4256.44" spread="50.1"/>
                    <measurement group_id="O6" value="4542.22" spread="42.8"/>
                    <measurement group_id="O7" value="5849.18" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="3899.39" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                    <measurement group_id="O10" value="2507.90" spread="NA">Geometric coefficient of variation was not derived as only one participant was evaluated for this arm.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax of MMAE for Dose-escalation Part</title>
        <description>The Tmax of MMAE for dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax of MMAE for Dose-escalation Part</title>
          <description>The Tmax of MMAE for dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>Day</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="3"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.95" lower_limit="2.95" upper_limit="2.95"/>
                    <measurement group_id="O2" value="3.00" lower_limit="3.00" upper_limit="3.00"/>
                    <measurement group_id="O3" value="2.938" lower_limit="2.89" upper_limit="2.94"/>
                    <measurement group_id="O4" value="2.764" lower_limit="2.72" upper_limit="2.83"/>
                    <measurement group_id="O5" value="2.852" lower_limit="0.97" upper_limit="3.03"/>
                    <measurement group_id="O6" value="2.866" lower_limit="1.00" upper_limit="6.85"/>
                    <measurement group_id="O7" value="2.942" lower_limit="2.82" upper_limit="7.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="15.950" lower_limit="15.93" upper_limit="17.73"/>
                    <measurement group_id="O9" value="15.982" lower_limit="15.97" upper_limit="15.99"/>
                    <measurement group_id="O10" value="15.911" lower_limit="14.51" upper_limit="15.95"/>
                    <measurement group_id="O11" value="20.820" lower_limit="20.82" upper_limit="20.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" lower_limit="2.83" upper_limit="2.83"/>
                    <measurement group_id="O2" value="2.87" lower_limit="2.87" upper_limit="2.87"/>
                    <measurement group_id="O3" value="0.94" lower_limit="0.94" upper_limit="0.94"/>
                    <measurement group_id="O4" value="2.83" lower_limit="2.83" upper_limit="2.83"/>
                    <measurement group_id="O5" value="2.830" lower_limit="0.94" upper_limit="3.96"/>
                    <measurement group_id="O6" value="2.727" lower_limit="0.94" upper_limit="2.94"/>
                    <measurement group_id="O7" value="3.02" lower_limit="3.02" upper_limit="3.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="14.93" lower_limit="14.93" upper_limit="14.93"/>
                    <measurement group_id="O10" value="15.890" lower_limit="15.89" upper_limit="15.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>t1/2 of MMAE for Dose-escalation Part</title>
        <description>The t1/2 of MMAE for dose-escalation part is reported.</description>
        <time_frame>For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3</time_frame>
        <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>t1/2 of MMAE for Dose-escalation Part</title>
          <description>The t1/2 of MMAE for dose-escalation part is reported.</description>
          <population>The PK analysis set included all participants who were exposed to at least 1 dose of enapotamab vedotin and who had at least 1 postdose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.</population>
          <units>Day</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cycle 1 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="3"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="10"/>
                    <count group_id="O6" value="10"/>
                    <count group_id="O7" value="2"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.19" lower_limit="2.19" upper_limit="2.19"/>
                    <measurement group_id="O2" value="2.35" lower_limit="2.35" upper_limit="2.35"/>
                    <measurement group_id="O3" value="2.470" lower_limit="2.10" upper_limit="2.70"/>
                    <measurement group_id="O4" value="2.620" lower_limit="1.85" upper_limit="2.98"/>
                    <measurement group_id="O5" value="2.420" lower_limit="2.02" upper_limit="3.75"/>
                    <measurement group_id="O6" value="3.128" lower_limit="1.55" upper_limit="42.73"/>
                    <measurement group_id="O7" value="2.835" lower_limit="2.45" upper_limit="3.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 1 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="3"/>
                    <count group_id="O9" value="3"/>
                    <count group_id="O10" value="6"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O8" value="3.976" lower_limit="2.78" upper_limit="6.06"/>
                    <measurement group_id="O9" value="3.115" lower_limit="2.49" upper_limit="5.04"/>
                    <measurement group_id="O10" value="4.739" lower_limit="2.85" upper_limit="8.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="4"/>
                    <count group_id="O7" value="1"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="0"/>
                    <count group_id="O10" value="0"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.94" lower_limit="1.94" upper_limit="1.94"/>
                    <measurement group_id="O2" value="2.32" lower_limit="2.32" upper_limit="2.32"/>
                    <measurement group_id="O3" value="2.71" lower_limit="2.71" upper_limit="2.71"/>
                    <measurement group_id="O4" value="2.52" lower_limit="2.52" upper_limit="2.52"/>
                    <measurement group_id="O5" value="2.746" lower_limit="2.18" upper_limit="3.12"/>
                    <measurement group_id="O6" value="3.364" lower_limit="2.85" upper_limit="4.99"/>
                    <measurement group_id="O7" value="1.98" lower_limit="1.98" upper_limit="1.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cycle 3 Day 15</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                    <count group_id="O9" value="1"/>
                    <count group_id="O10" value="1"/>
                    <count group_id="O11" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O9" value="2.330" lower_limit="2.33" upper_limit="2.33"/>
                    <measurement group_id="O10" value="3.37" lower_limit="3.37" upper_limit="3.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Antidrug Antibodies (ADAs) Confirmed Positive to Enapotamab Vedotin</title>
        <description>The ADA assessment was performed according to a tiered approach. First samples were screened for an ADA response; positively screened samples were analyzed in a confirmation method. Subsequently confirmed positive samples were analyzed for titre and the presence of neutralizing antibodies. Number of participants with ADA confirmed positive to enapotamab vedotin is reported.</description>
        <time_frame>Day 1 through Day 1130 (Dose-escalation part: Predose of Day 1 of Cycles 1 to 12, end of treatment [EOT], and 30 days after last study drug; Expansion part: Predose on Day 1 of Cycles 1 to 5, then every fourth cycle until PD)</time_frame>
        <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Antidrug Antibodies (ADAs) Confirmed Positive to Enapotamab Vedotin</title>
          <description>The ADA assessment was performed according to a tiered approach. First samples were screened for an ADA response; positively screened samples were analyzed in a confirmation method. Subsequently confirmed positive samples were analyzed for titre and the presence of neutralizing antibodies. Number of participants with ADA confirmed positive to enapotamab vedotin is reported.</description>
          <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="56"/>
                <count group_id="O19" value="20"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="4"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="7"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Objective Response (OR) Based on Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) As Assessed by Investigator</title>
        <description>Radiological evaluation based on RECIST v1.1 was performed by the investigator using computed tomography (CT) scans/ magnetic resonance imaging (MRI) scans/ positron emission tomography (PET) scans. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to &lt; 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD.</description>
        <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
        <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Objective Response (OR) Based on Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) As Assessed by Investigator</title>
          <description>Radiological evaluation based on RECIST v1.1 was performed by the investigator using computed tomography (CT) scans/ magnetic resonance imaging (MRI) scans/ positron emission tomography (PET) scans. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to &lt; 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD.</description>
          <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="55"/>
                <count group_id="O19" value="21"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="4"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="5"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Best Cancer Antigen 125 (CA-125) Response</title>
        <description>The best CA-125 response was evaluated in participants with ovarian cancer. A CA-125 partial response was defined as at least a 50% reduction in CA-125 levels in blood from a pretreatment sample. Participants who had a CA-125 partial response and had CA-125 level falls to within the reference range (0-35 units/mL) were classified as CA-125 complete responders. The response was confirmed and maintained for at least 28 days. The best overall response (CA-125 partial response and CA-125 complete response) is reported.</description>
        <time_frame>From Screening (within 2 weeks before starting of the study treatment) through Day 1130 (maximum observed duration)</time_frame>
        <population>Participants from the full analysis set with ovarian cancer who had an initial CA-125 level of at least twice the upper limit of the reference range within 2 weeks before starting the study treatment were evaluated for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Best Cancer Antigen 125 (CA-125) Response</title>
          <description>The best CA-125 response was evaluated in participants with ovarian cancer. A CA-125 partial response was defined as at least a 50% reduction in CA-125 levels in blood from a pretreatment sample. Participants who had a CA-125 partial response and had CA-125 level falls to within the reference range (0-35 units/mL) were classified as CA-125 complete responders. The response was confirmed and maintained for at least 28 days. The best overall response (CA-125 partial response and CA-125 complete response) is reported.</description>
          <population>Participants from the full analysis set with ovarian cancer who had an initial CA-125 level of at least twice the upper limit of the reference range within 2 weeks before starting the study treatment were evaluated for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="3"/>
                <count group_id="O6" value="3"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="0"/>
                <count group_id="O10" value="2"/>
                <count group_id="O11" value="2"/>
                <count group_id="O12" value="0"/>
                <count group_id="O13" value="0"/>
                <count group_id="O14" value="0"/>
                <count group_id="O15" value="0"/>
                <count group_id="O16" value="0"/>
                <count group_id="O17" value="19"/>
                <count group_id="O18" value="0"/>
                <count group_id="O19" value="0"/>
                <count group_id="O20" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>CA-125 partial response</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O17" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CA-125 complete response</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O17" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Response (DoR) Based on RECIST v1.1 as Assessed by Investigator for Expansion Part</title>
        <description>The DoR was defined as the number of months from the first documentation of objective tumor response (CR or PR) to the date of first progressive disease (PD) or death. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to &lt; 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD. The PD was defined as at least 20% increase in the sum of LD of target lesions taking as reference the smallest sum of the LD recorded since the treatment started or the appearance of one or more new target and non-target lesions and/or unequivocal progression of existing non-target lesions.</description>
        <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
        <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received. Participants who achieved confirmed OR by the investigator assessment were evaluated for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Response (DoR) Based on RECIST v1.1 as Assessed by Investigator for Expansion Part</title>
          <description>The DoR was defined as the number of months from the first documentation of objective tumor response (CR or PR) to the date of first progressive disease (PD) or death. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to &lt; 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD. The PD was defined as at least 20% increase in the sum of LD of target lesions taking as reference the smallest sum of the LD recorded since the treatment started or the appearance of one or more new target and non-target lesions and/or unequivocal progression of existing non-target lesions.</description>
          <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received. Participants who achieved confirmed OR by the investigator assessment were evaluated for this outcome measure.</population>
          <units>Months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="2"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
                <count group_id="O9" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="4.2" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O3" value="4.1" lower_limit="2.4" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O5" value="4.9" lower_limit="2.6" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O6" value="3.0" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O7" value="NA" lower_limit="3.0" upper_limit="NA">Median and upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O8" value="3.0" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O9" value="4.9" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Progression Free Survival (PFS) as Assessed by Investigator</title>
        <description>The PFS was defined as the number of months from the date of first study drug administration to first PD or death. The PD was defined as at least 20% increase in the sum of longest diameters of target lesions taking as reference the smallest sum of the longest diameters recorded since the treatment started or the appearance of one or more new lesions. The PFS was estimated using Kaplan-Meier method.</description>
        <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
        <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Progression Free Survival (PFS) as Assessed by Investigator</title>
          <description>The PFS was defined as the number of months from the date of first study drug administration to first PD or death. The PD was defined as at least 20% increase in the sum of longest diameters of target lesions taking as reference the smallest sum of the longest diameters recorded since the treatment started or the appearance of one or more new lesions. The PFS was estimated using Kaplan-Meier method.</description>
          <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received.</population>
          <units>Months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="55"/>
                <count group_id="O19" value="21"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O2" value="3.5" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O3" value="1.3" lower_limit="1.2" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O4" value="5.3" lower_limit="1.1" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O5" value="2.8" lower_limit="1.4" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O6" value="2.6" lower_limit="0.7" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O7" value="NA" lower_limit="NA" upper_limit="NA">Median and 95% confidence interval were not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O8" value="1.6" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O9" value="1.6" lower_limit="1.3" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O10" value="4.3" lower_limit="1.0" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O11" value="0.8" lower_limit="0.4" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O12" value="2.6" lower_limit="1.2" upper_limit="2.8"/>
                    <measurement group_id="O13" value="2.6" lower_limit="1.2" upper_limit="3.9"/>
                    <measurement group_id="O14" value="2.8" lower_limit="1.3" upper_limit="5.0"/>
                    <measurement group_id="O15" value="2.6" lower_limit="1.4" upper_limit="4.1"/>
                    <measurement group_id="O16" value="1.9" lower_limit="1.6" upper_limit="2.1"/>
                    <measurement group_id="O17" value="1.6" lower_limit="1.3" upper_limit="3.0"/>
                    <measurement group_id="O18" value="2.2" lower_limit="1.4" upper_limit="3.9"/>
                    <measurement group_id="O19" value="2.6" lower_limit="1.1" upper_limit="4.0"/>
                    <measurement group_id="O20" value="2.0" lower_limit="1.4" upper_limit="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Survival (OS)</title>
        <description>Overall survival was defined as the number of months from date of first study drug administration to death. The OS was estimated using Kaplan-Meier method.</description>
        <time_frame>Day 1 through 44.5 months (maximum observed duration)</time_frame>
        <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.st.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival (OS)</title>
          <description>Overall survival was defined as the number of months from date of first study drug administration to death. The OS was estimated using Kaplan-Meier method.</description>
          <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received.</population>
          <units>Months</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="55"/>
                <count group_id="O19" value="21"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">Median and 95% confidence interval were not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O2" value="4.3" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O3" value="6.4" lower_limit="6.3" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O4" value="NA" lower_limit="6.7" upper_limit="NA">Median and upper limit of 95% confidence interval were not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O5" value="14.5" lower_limit="3.1" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O6" value="7.6" lower_limit="2.2" upper_limit="12.1"/>
                    <measurement group_id="O7" value="44.5" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O8" value="6.7" lower_limit="6.7" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O9" value="14.3" lower_limit="NA" upper_limit="NA">95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O10" value="7.7" lower_limit="4.3" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O11" value="21.7" lower_limit="0.4" upper_limit="NA">Upper limit of 95% confidence interval was not reached due to an insufficient events being observed.</measurement>
                    <measurement group_id="O12" value="16.5" lower_limit="4.1" upper_limit="25.9"/>
                    <measurement group_id="O13" value="8.6" lower_limit="3.6" upper_limit="19.1"/>
                    <measurement group_id="O14" value="9.2" lower_limit="4.0" upper_limit="14.9"/>
                    <measurement group_id="O15" value="17.1" lower_limit="5.7" upper_limit="24.3"/>
                    <measurement group_id="O16" value="7.0" lower_limit="5.2" upper_limit="11.6"/>
                    <measurement group_id="O17" value="8.4" lower_limit="6.5" upper_limit="12.4"/>
                    <measurement group_id="O18" value="11.3" lower_limit="8.0" upper_limit="15.5"/>
                    <measurement group_id="O19" value="8.7" lower_limit="5.8" upper_limit="14.1"/>
                    <measurement group_id="O20" value="8.0" lower_limit="4.1" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in AXL Expression (Total Tumor H-score) From Baseline to EOT Visit for Expansion Part</title>
        <description>Change in AXL expression (total humor H-score in membrane or cytoplasm) from Baseline to EOT visit for the expansion part is reported. The H-score captures both the intensity and proportion of AXL positive tumor cells and was defined by the formula: H-score = (1 × % 1+ tumor cells) + (2 × % 2+ tumor cells) + (3 × % 3+ tumor cells); where '1+' indicates weak staining intensity, '2+' indicates medium staining intensity, and '3+' indicates strong staining intensity. The H-score values ranges from 0 to 300. Lower H-scores represent lower AXL expression in the tumor sample, while higher scores represent stronger AXL expression in the tumor samples.</description>
        <time_frame>Baseline (Study Days -21 to 1) and EOT visit (Day 1100)</time_frame>
        <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received in the expansion part. Participants who had tumor H-scores in membrane or cytoplasm assessed at Baseline and at the end of treatment visit were evaluated for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in AXL Expression (Total Tumor H-score) From Baseline to EOT Visit for Expansion Part</title>
          <description>Change in AXL expression (total humor H-score in membrane or cytoplasm) from Baseline to EOT visit for the expansion part is reported. The H-score captures both the intensity and proportion of AXL positive tumor cells and was defined by the formula: H-score = (1 × % 1+ tumor cells) + (2 × % 2+ tumor cells) + (3 × % 3+ tumor cells); where '1+' indicates weak staining intensity, '2+' indicates medium staining intensity, and '3+' indicates strong staining intensity. The H-score values ranges from 0 to 300. Lower H-scores represent lower AXL expression in the tumor sample, while higher scores represent stronger AXL expression in the tumor samples.</description>
          <population>The full analysis set included all participants who received at least 1 dose of enapotamab vedotin. Participants were classified according to first dose received in the expansion part. Participants who had tumor H-scores in membrane or cytoplasm assessed at Baseline and at the end of treatment visit were evaluated for this outcome measure.</population>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="0"/>
                <count group_id="O9" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.0" spread="NA">Standard deviation was not derived as only one participant was evaluated.</measurement>
                    <measurement group_id="O2" value="-1.0" spread="NA">Standard deviation was not derived as only one participant was evaluated.</measurement>
                    <measurement group_id="O4" value="-30.0" spread="NA">Standard deviation was not derived as only one participant was evaluated.</measurement>
                    <measurement group_id="O6" value="35.0" spread="NA">Standard deviation was not derived as only one participant was evaluated.</measurement>
                    <measurement group_id="O7" value="-14.0" spread="NA">Standard deviation was not derived as only one participant was evaluated.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Grade 3 or 4 Laboratory Results</title>
        <description>Number of participants with laboratory measurements graded as Grade 3 or 4 by NCI-CTCAE v 4.03 is reported.</description>
        <time_frame>Day 1 through Day 1130 (maximum observed duration)</time_frame>
        <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
        <group_list>
          <group group_id="O1">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O2">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O3">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O4">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O5">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O6">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O7">
            <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O8">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O9">
            <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O10">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O11">
            <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
            <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O12">
            <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O13">
            <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O14">
            <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O15">
            <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O16">
            <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
          <group group_id="O17">
            <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O18">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O19">
            <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
          </group>
          <group group_id="O20">
            <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
            <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Grade 3 or 4 Laboratory Results</title>
          <description>Number of participants with laboratory measurements graded as Grade 3 or 4 by NCI-CTCAE v 4.03 is reported.</description>
          <population>The safety set included all participants who received at least 1 dose of enapotamab vedotin and had at least one valid post-baseline safety assessment. Participants were classified according to first dose received.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="3"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="11"/>
                <count group_id="O7" value="3"/>
                <count group_id="O8" value="3"/>
                <count group_id="O9" value="3"/>
                <count group_id="O10" value="6"/>
                <count group_id="O11" value="3"/>
                <count group_id="O12" value="22"/>
                <count group_id="O13" value="16"/>
                <count group_id="O14" value="25"/>
                <count group_id="O15" value="25"/>
                <count group_id="O16" value="44"/>
                <count group_id="O17" value="25"/>
                <count group_id="O18" value="56"/>
                <count group_id="O19" value="20"/>
                <count group_id="O20" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Activated partial thromboplastin time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alanine aminotransferase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Amylase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aspartate aminotransferase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Calcium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gamma-glutamyl transferase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="4"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="2"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="3"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="7"/>
                    <measurement group_id="O17" value="4"/>
                    <measurement group_id="O18" value="8"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Leukocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lipase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="4"/>
                    <measurement group_id="O19" value="3"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lymphocytes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="2"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="5"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="5"/>
                    <measurement group_id="O15" value="7"/>
                    <measurement group_id="O16" value="9"/>
                    <measurement group_id="O17" value="8"/>
                    <measurement group_id="O18" value="9"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Magnesium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Neutrophils</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="4"/>
                    <measurement group_id="O15" value="7"/>
                    <measurement group_id="O16" value="3"/>
                    <measurement group_id="O17" value="5"/>
                    <measurement group_id="O18" value="8"/>
                    <measurement group_id="O19" value="2"/>
                    <measurement group_id="O20" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Potassium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="1"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prothrombin Intl. Normalized Ratio</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="2"/>
                    <measurement group_id="O18" value="4"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sodium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="3"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="1"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="4"/>
                    <measurement group_id="O16" value="2"/>
                    <measurement group_id="O17" value="3"/>
                    <measurement group_id="O18" value="7"/>
                    <measurement group_id="O19" value="1"/>
                    <measurement group_id="O20" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="2"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="2"/>
                    <measurement group_id="O14" value="2"/>
                    <measurement group_id="O15" value="3"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alkaline Phosphatase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="1"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="1"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="1"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hemoglobin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="1"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="3"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="2"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Albumin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="1"/>
                    <measurement group_id="O15" value="1"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="0"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="1"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cholesterol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                    <measurement group_id="O9" value="0"/>
                    <measurement group_id="O10" value="0"/>
                    <measurement group_id="O11" value="0"/>
                    <measurement group_id="O12" value="1"/>
                    <measurement group_id="O13" value="0"/>
                    <measurement group_id="O14" value="0"/>
                    <measurement group_id="O15" value="0"/>
                    <measurement group_id="O16" value="0"/>
                    <measurement group_id="O17" value="0"/>
                    <measurement group_id="O18" value="0"/>
                    <measurement group_id="O19" value="0"/>
                    <measurement group_id="O20" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>For TEAEs: Day 1 through Day 1130 and for all-cause mortality: From date of inform consent form until death (up to 44.5 months) (maximum observed duration)</time_frame>
      <desc>The TEAEs were evaluated per the safety set and all-cause mortality was evaluated per the full analysis set.</desc>
      <group_list>
        <group group_id="E1">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.3 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.3 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E2">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E3">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E4">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.5 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.5 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E5">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.0 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.0 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E6">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E7">
          <title>Dose-escalation Part: Enapotamab Vedotin 2.4 mg/kg 1Q3W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 2.4 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E8">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.6 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.6 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="E9">
          <title>Dose-escalation Part: Enapotamab Vedotin 0.8 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 0.8 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="E10">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="E11">
          <title>Dose-escalation Part: Enapotamab Vedotin 1.2 mg/kg 3Q4W</title>
          <description>Participants with relapsed/refractory cancer (ovarian, cervical, endometrial, thyroid, NSCLC, or melanoma) received IV infusion of enapotamab vedotin 1.2 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="E12">
          <title>Expansion Part Cohort 1: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC with classical sensitizing classical EGFR mutations and/or EGFR mutations targeted by third-generation tyrosine kinase inhibitors) received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E13">
          <title>Expansion Part Cohort 3: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic melanoma with BRAF V600 mutation received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E14">
          <title>Expansion Part Cohort 4: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic melanoma with BRAF V600 wild type received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E15">
          <title>Expansion Part Cohort 5: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic sarcoma received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E16">
          <title>Expansion Part Cohort 6: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with advanced and/or metastatic solid tumors (excluding NSCLC, melanoma, sarcoma, and ovarian cancer unless having a known AXL gene amplification) received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
        <group group_id="E17">
          <title>Expansion Part Cohort 7: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic platinum-resistant ovarian cancer received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E18">
          <title>Expansion Part Cohort 2: Enapotamab Vedotin 2.2 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 2.2 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E19">
          <title>Expansion Part Cohort 2: Enapotamab Vedotin 1.8 mg/kg 1Q3W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.8 mg/kg 1Q3W until the end of treatment.</description>
        </group>
        <group group_id="E20">
          <title>Expansion Part Cohort 8: Enapotamab Vedotin 1.0 mg/kg 3Q4W</title>
          <description>Participants with advanced and/or metastatic NSCLC without activating EGFR mutations or ALK rearrangements received IV infusion of enapotamab vedotin 1.0 mg/kg 3Q4W until the end of treatment.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (v24.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="11"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="6"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="8" subjects_at_risk="22"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="16"/>
                <counts group_id="E14" subjects_affected="17" subjects_at_risk="25"/>
                <counts group_id="E15" subjects_affected="18" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="30" subjects_at_risk="44"/>
                <counts group_id="E17" subjects_affected="17" subjects_at_risk="25"/>
                <counts group_id="E18" subjects_affected="38" subjects_at_risk="56"/>
                <counts group_id="E19" subjects_affected="14" subjects_at_risk="22"/>
                <counts group_id="E20" subjects_affected="16" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="11"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="15" subjects_at_risk="22"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="16"/>
                <counts group_id="E14" subjects_affected="16" subjects_at_risk="25"/>
                <counts group_id="E15" subjects_affected="10" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="16" subjects_at_risk="44"/>
                <counts group_id="E17" subjects_affected="12" subjects_at_risk="25"/>
                <counts group_id="E18" subjects_affected="33" subjects_at_risk="56"/>
                <counts group_id="E19" subjects_affected="7" subjects_at_risk="20"/>
                <counts group_id="E20" subjects_affected="14" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Inappropriate Antidiuretic Hormone Secretion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="7" subjects_affected="7" subjects_at_risk="22"/>
                <counts group_id="E13" events="4" subjects_affected="4" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="6" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>General Physical Health Deterioration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Influenza Like Illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Multiple Organ Dysfunction Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Drug-Induced Liver Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Portal Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cholangitis Infective</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neutropenic Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumocystis Jirovecii Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Staphylococcal Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood Creatine Phosphokinase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lipase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lymphocyte Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neutrophil Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Bone Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Flank Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Lymphangiosis Carcinomatosa</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Malignant Neoplasm Progression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Metastases to Central Nervous System</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Metastases to Peritoneum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neoplasm Progression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Motor-Sensory Axonal Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Loss Of Consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Monoplegia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Partial Seizures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral Motor Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral Sensorimotor Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device Occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Psychotic Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Respiratory Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tracheal Obstruction Extrinsic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (v24.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="10"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="11"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="6"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="22" subjects_at_risk="22"/>
                <counts group_id="E13" subjects_affected="16" subjects_at_risk="16"/>
                <counts group_id="E14" subjects_affected="24" subjects_at_risk="25"/>
                <counts group_id="E15" subjects_affected="25" subjects_at_risk="25"/>
                <counts group_id="E16" subjects_affected="44" subjects_at_risk="44"/>
                <counts group_id="E17" subjects_affected="25" subjects_at_risk="25"/>
                <counts group_id="E18" subjects_affected="56" subjects_at_risk="56"/>
                <counts group_id="E19" subjects_affected="20" subjects_at_risk="20"/>
                <counts group_id="E20" subjects_affected="23" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="8" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="10" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E14" events="6" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="6" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E16" events="8" subjects_affected="6" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E18" events="14" subjects_affected="11" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Anaemia Macrocytic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Anaemia of chronic disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Febrile Neutropenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="4" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="9" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lymphopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="29" subjects_affected="4" subjects_at_risk="10"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="6" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E14" events="11" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E15" events="13" subjects_affected="7" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="14" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E18" events="9" subjects_affected="7" subjects_at_risk="56"/>
                <counts group_id="E19" events="5" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Normocytic Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sinus Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="4" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ventricular Extrasystoles</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Borderline Glaucoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Conjunctival Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dry Eye</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Eye Irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Eye Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lacrimation Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ocular Hyperaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Trichomegaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vision Blurred</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Visual Impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vitreous Floaters</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal Distension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="8" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E6" events="7" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E7" events="4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="7" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="6" subjects_affected="4" subjects_at_risk="16"/>
                <counts group_id="E14" events="8" subjects_affected="8" subjects_at_risk="25"/>
                <counts group_id="E15" events="5" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E16" events="10" subjects_affected="10" subjects_at_risk="44"/>
                <counts group_id="E17" events="13" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E18" events="14" subjects_affected="11" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="13" subjects_affected="7" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="14" subjects_affected="8" subjects_at_risk="10"/>
                <counts group_id="E6" events="10" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="8" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="9" subjects_affected="7" subjects_at_risk="22"/>
                <counts group_id="E13" events="9" subjects_affected="5" subjects_at_risk="16"/>
                <counts group_id="E14" events="15" subjects_affected="12" subjects_at_risk="25"/>
                <counts group_id="E15" events="16" subjects_affected="13" subjects_at_risk="25"/>
                <counts group_id="E16" events="13" subjects_affected="11" subjects_at_risk="44"/>
                <counts group_id="E17" events="9" subjects_affected="7" subjects_at_risk="25"/>
                <counts group_id="E18" events="39" subjects_affected="31" subjects_at_risk="56"/>
                <counts group_id="E19" events="9" subjects_affected="9" subjects_at_risk="20"/>
                <counts group_id="E20" events="13" subjects_affected="11" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="11" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E6" events="13" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="9" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="7" subjects_affected="5" subjects_at_risk="22"/>
                <counts group_id="E13" events="10" subjects_affected="8" subjects_at_risk="16"/>
                <counts group_id="E14" events="13" subjects_affected="10" subjects_at_risk="25"/>
                <counts group_id="E15" events="21" subjects_affected="10" subjects_at_risk="25"/>
                <counts group_id="E16" events="17" subjects_affected="13" subjects_at_risk="44"/>
                <counts group_id="E17" events="10" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E18" events="28" subjects_affected="20" subjects_at_risk="56"/>
                <counts group_id="E19" events="6" subjects_affected="6" subjects_at_risk="20"/>
                <counts group_id="E20" events="18" subjects_affected="11" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dry Mouth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="5" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="8" subjects_affected="5" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Duodenogastric Reflux</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Epigastric Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastric Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gingival Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gingival Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hiatus Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia Teeth</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Impaired Gastric Emptying</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E5" events="9" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E6" events="17" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E7" events="7" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E10" events="6" subjects_affected="4" subjects_at_risk="6"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E12" events="18" subjects_affected="14" subjects_at_risk="22"/>
                <counts group_id="E13" events="12" subjects_affected="10" subjects_at_risk="16"/>
                <counts group_id="E14" events="12" subjects_affected="11" subjects_at_risk="25"/>
                <counts group_id="E15" events="20" subjects_affected="15" subjects_at_risk="25"/>
                <counts group_id="E16" events="19" subjects_affected="13" subjects_at_risk="44"/>
                <counts group_id="E17" events="22" subjects_affected="15" subjects_at_risk="25"/>
                <counts group_id="E18" events="30" subjects_affected="22" subjects_at_risk="56"/>
                <counts group_id="E19" events="7" subjects_affected="6" subjects_at_risk="20"/>
                <counts group_id="E20" events="16" subjects_affected="11" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neutropenic Colitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Salivary Duct Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E5" events="13" subjects_affected="6" subjects_at_risk="10"/>
                <counts group_id="E6" events="11" subjects_affected="7" subjects_at_risk="11"/>
                <counts group_id="E7" events="6" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="3" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="6" subjects_at_risk="22"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="10" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E16" events="15" subjects_affected="9" subjects_at_risk="44"/>
                <counts group_id="E17" events="8" subjects_affected="7" subjects_at_risk="25"/>
                <counts group_id="E18" events="21" subjects_affected="15" subjects_at_risk="56"/>
                <counts group_id="E19" events="4" subjects_affected="4" subjects_at_risk="20"/>
                <counts group_id="E20" events="16" subjects_affected="7" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Application Site Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Axillary Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Chest Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="5" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="5" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="4" subjects_affected="4" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="5" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Condition Aggravated</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Face Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E5" events="5" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E6" events="10" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="14" subjects_affected="5" subjects_at_risk="6"/>
                <counts group_id="E11" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E12" events="15" subjects_affected="15" subjects_at_risk="22"/>
                <counts group_id="E13" events="9" subjects_affected="8" subjects_at_risk="16"/>
                <counts group_id="E14" events="22" subjects_affected="16" subjects_at_risk="25"/>
                <counts group_id="E15" events="22" subjects_affected="14" subjects_at_risk="25"/>
                <counts group_id="E16" events="31" subjects_affected="23" subjects_at_risk="44"/>
                <counts group_id="E17" events="17" subjects_affected="13" subjects_at_risk="25"/>
                <counts group_id="E18" events="37" subjects_affected="31" subjects_at_risk="56"/>
                <counts group_id="E19" events="13" subjects_affected="11" subjects_at_risk="20"/>
                <counts group_id="E20" events="14" subjects_affected="13" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Feeling Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gait Disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hernia Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Influenza Like Illness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Infusion Site Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Localised Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Medical Device Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Mucosal Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nodule</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Non-cardiac Chest Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="6" subjects_affected="4" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Physical Deconditioning</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="5" subjects_at_risk="22"/>
                <counts group_id="E13" events="4" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E14" events="6" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="6" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="7" subjects_affected="7" subjects_at_risk="56"/>
                <counts group_id="E19" events="4" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Soft Tissue Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Temperature Intolerance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tenderness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vaccination Site Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Xerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary Colic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hepatic Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hepatic Steatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteriuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>COVID-19</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Candida Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Citrobacter Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cystitis Escherichia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Escherichia Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Eye Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fungal Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fungal Oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Herpes Simplex</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lung Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="4" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oral Candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="5" subjects_affected="5" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Parainfluenzae Virus Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="6" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash Pustular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Skin Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tooth Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Urinary Tract Candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="5" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="4" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="5" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="8" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vaginal Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Clavicle Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Compression Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Infusion Related Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ligament Sprain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lip Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lumbar Vertebral Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Post Procedural Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Post Procedural Swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Procedural Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Radiation Necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tendon Rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Thermal Burn</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Wrist Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Activated Partial Thromboplastin Time Prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Alanine Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="5" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E7" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="6" subjects_at_risk="22"/>
                <counts group_id="E13" events="4" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E14" events="6" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="9" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="6" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E18" events="11" subjects_affected="10" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Amylase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="4" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E18" events="6" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Aspartate Aminotransferase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="9" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="4" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="6" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="10" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="7" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E18" events="17" subjects_affected="13" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Albumin Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Alkaline Phosphatase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="6" subjects_affected="6" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Bilirubin Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="4" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Cholesterol Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Creatine Phosphokinase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="5" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Iron Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Lactate Dehydrogenase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Magnesium Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Phosphorus Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Potassium Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Sodium Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Thyroid Stimulating Hormone Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Triglycerides Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blood Urea Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Brain Natriuretic Peptide Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Breath Sounds Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>C-reactive Protein Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="6" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT Prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Gamma-glutamyltransferase Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="6" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Glomerular Filtration Rate Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="4" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lipase Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="5" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lymphocyte Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="4" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neutrophil Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Platelet Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>SARS-CoV-2 Test Positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Staphylococcus Test Positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Troponin T Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Troponin Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vitamin B12 Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Weight Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="5" subjects_affected="5" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="8" subjects_affected="8" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="13" subjects_affected="13" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="5" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Weight Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>White Blood Cells Urine Positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypermagnesaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased Appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="3" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="10"/>
                <counts group_id="E6" events="12" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E7" events="5" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="4" subjects_affected="3" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="10" subjects_affected="8" subjects_at_risk="22"/>
                <counts group_id="E13" events="8" subjects_affected="8" subjects_at_risk="16"/>
                <counts group_id="E14" events="6" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E15" events="11" subjects_affected="8" subjects_at_risk="25"/>
                <counts group_id="E16" events="14" subjects_affected="14" subjects_at_risk="44"/>
                <counts group_id="E17" events="7" subjects_affected="7" subjects_at_risk="25"/>
                <counts group_id="E18" events="31" subjects_affected="26" subjects_at_risk="56"/>
                <counts group_id="E19" events="7" subjects_affected="7" subjects_at_risk="20"/>
                <counts group_id="E20" events="16" subjects_affected="12" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fluid Overload</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="4" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypernatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="6" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypoalbuminaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="6" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E8" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="8" subjects_affected="7" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="5" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="17" subjects_affected="12" subjects_at_risk="56"/>
                <counts group_id="E19" events="5" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="4" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="20" subjects_affected="10" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="6" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="7" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="11" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="6" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypophagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="7" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Iron Deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vitamin D Deficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Muscle Tightness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="9" subjects_affected="7" subjects_at_risk="25"/>
                <counts group_id="E16" events="6" subjects_affected="6" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="13" subjects_affected="8" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="5" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="6" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="6" subjects_affected="6" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="10" subjects_affected="9" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="4" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Bone Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Flank Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="4" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Groin Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Joint Range of Motion Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Limb Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Mobility Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="5" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Muscular Weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Stiffness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="6" subjects_affected="4" subjects_at_risk="16"/>
                <counts group_id="E14" events="5" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="6" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E16" events="4" subjects_affected="4" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="6" subjects_affected="5" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pain in Extremity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="6" subjects_affected="5" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amputation Stump Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Autonomic Nervous System Imbalance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Autonomic Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Balance Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cognitive Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Depressed Level of Consciousness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Disturbance in Attention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="3" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="4" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="5" subjects_affected="5" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="5" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E16" events="7" subjects_affected="6" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="5" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="4" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="5" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E16" events="11" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E17" events="6" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E18" events="7" subjects_affected="5" subjects_at_risk="56"/>
                <counts group_id="E19" events="4" subjects_affected="4" subjects_at_risk="20"/>
                <counts group_id="E20" events="10" subjects_affected="4" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Metabolic Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Mononeuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Monoplegia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neuropathy Peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="6" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Neurotoxicity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Paresis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Parosmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral Motor Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="4" subjects_affected="4" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral Sensorimotor Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="5" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peripheral Sensory Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="6" subjects_affected="5" subjects_at_risk="10"/>
                <counts group_id="E6" events="4" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="14" subjects_affected="9" subjects_at_risk="22"/>
                <counts group_id="E13" events="3" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="11" subjects_affected="7" subjects_at_risk="25"/>
                <counts group_id="E16" events="14" subjects_affected="11" subjects_at_risk="44"/>
                <counts group_id="E17" events="6" subjects_affected="6" subjects_at_risk="25"/>
                <counts group_id="E18" events="11" subjects_affected="11" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="7" subjects_affected="7" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Peroneal Nerve Palsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pyramidal Tract Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Restless Legs Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="5" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Spinal Cord Compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Taste Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Confusional State</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Depressed Mood</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="2" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hallucination, Olfactory</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hallucination, Visual</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="5" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E17" events="5" subjects_affected="5" subjects_at_risk="25"/>
                <counts group_id="E18" events="8" subjects_affected="8" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="7" subjects_affected="7" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Kidney Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Bladder Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Calculus Bladder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypertonic Bladder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nocturia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Urge Incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Breast Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Perineal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vaginal Discharge</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vaginal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Dryness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Adductor Vocal Cord Weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="4" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="6" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="5" subjects_affected="5" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="10" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysaesthesia Pharynx</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="4" subjects_affected="4" subjects_at_risk="44"/>
                <counts group_id="E17" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="8" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E19" events="7" subjects_affected="6" subjects_at_risk="20"/>
                <counts group_id="E20" events="12" subjects_affected="10" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dyspnoea Exertional</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nasal Congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nasal Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Paranasal Sinus Discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pleuritic Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Productive Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pulmonary Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rhinitis Allergic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sinus Congestion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sinus Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Sinus Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Upper-airway Cough Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vasomotor Rhinitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="10"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="4" subjects_affected="4" subjects_at_risk="22"/>
                <counts group_id="E13" events="5" subjects_affected="5" subjects_at_risk="16"/>
                <counts group_id="E14" events="7" subjects_affected="7" subjects_at_risk="25"/>
                <counts group_id="E15" events="9" subjects_affected="8" subjects_at_risk="25"/>
                <counts group_id="E16" events="3" subjects_affected="3" subjects_at_risk="44"/>
                <counts group_id="E17" events="9" subjects_affected="9" subjects_at_risk="25"/>
                <counts group_id="E18" events="14" subjects_affected="14" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="6" subjects_affected="6" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dermatitis Allergic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dermatitis Bullous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dermatitis Contact</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Dry Skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="2" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Erythema Multiforme</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hair Texture Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Lichenoid Keratosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nail Discolouration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nail Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Nail Dystrophy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Night Sweats</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="3" subjects_affected="2" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Onychoclasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="22"/>
                <counts group_id="E13" events="4" subjects_affected="3" subjects_at_risk="16"/>
                <counts group_id="E14" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="7" subjects_affected="6" subjects_at_risk="44"/>
                <counts group_id="E17" events="4" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E18" events="7" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="3" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="5" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E17" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E18" events="7" subjects_affected="6" subjects_at_risk="56"/>
                <counts group_id="E19" events="4" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E20" events="5" subjects_affected="3" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash Erythematous</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="2" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash Macular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash Maculo-papular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Rash Pruritic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Skin Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Skin Hyperpigmentation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Skin Irritation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Skin Lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Skin Mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Skin Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hot Flush</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="3" subjects_affected="3" subjects_at_risk="22"/>
                <counts group_id="E13" events="4" subjects_affected="4" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="9" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="4" subjects_affected="4" subjects_at_risk="25"/>
                <counts group_id="E18" events="3" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="2" subjects_affected="2" subjects_at_risk="25"/>
                <counts group_id="E15" events="3" subjects_affected="3" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="7" subjects_affected="7" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Jugular Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="16"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis Superficial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Vascular Compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E19" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E20" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is at least 12 months but less than 18 months from the end of study (database lock). The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No participants with castration-resistant prostate cancer were enrolled, hence no prostate-specific antigen (PSA) data were available and pre-specified outcome measure related to PSA data are not reported.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Clinical Trial Information</name_or_title>
      <organization>Genmab A/S</organization>
      <phone>+45 7020 2728</phone>
      <email>clinicaltrials@genmab.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>


download date: ClinicalTrials.gov processed this data on September 20, 2023
link text: Link to the current ClinicalTrials.gov record.
url: https://clinicaltrials.gov/ct2/show/NCT02988817
org study id: GCT1021-01
secondary id: 2016-002243-42
secondary id: 211258
nct id: NCT02988817
lead sponsor: 
has dmc: Yes
is fda regulated drug: Yes
The purpose of the trial is to determine the maximum tolerated dose and to establish the
      safety profile of HuMax-AXL-ADC in a mixed population of patients with specified solid tumors
The trial consists of two parts; a dose escalation part (phase I, first in-human (FIH)) and
      an expansion part (phase IIa).

      The dose escalation part has 2 dosing schedules: 1 dose every 3 weeks (1Q3W) dose regimen,
      and 3 doses every 4 weeks (3Q4W) dosing regimen.

      The Expansion part of the trial will further explore the recommended phase 2 dose and dosing
      regimens of HuMax-AXL-ADC as determined in dose escalation part.
allocation: N/A
intervention model: Sequential Assignment
primary purpose: Treatment
masking: None (Open Label)
measure: Number of Participants With Dose-limiting Toxicities (DLTs) for Dose-escalation Part
time frame: From Day 1 to Day 21 of first cycle for 1Q3W dosing regimen and from Day 1 to Day 28 of first cycle for 3Q4W dosing regimen
description: The DLTs were defined as Grade (G) 4 neutropenia or G4 thrombocytopenia for a minimal duration of 7 days, G3 and G4 febrile neutropenia, >=G3 hemorrhage associated with >=G3 thrombocytopenia, G4 anemia; Stevens Johnson syndrome, toxic epidermal necrolysis, >=G3 cutaneous vasculitis; G3 neuropathy (not improved to G1 within 3 weeks following pausing of dosing) and G4 neuropathy; G3 infusion-related reactions (IRR) that did not resolve to G1 or baseline within 24 hours; G4 IRR or G4 anaphylaxis events; >= G3 diarrhoea and/or vomiting persisting >48 hours or G3 nausea lasting 7 days (both despite optimal medical management); or any >=G3 related non-hematological AEs, which occurred during the Cycle 1 and regarded as medically important as assessed by the Data Monitoring Committee (excluding Grade 3 fatigue or non-hematological laboratory abnormalities as specified in protocol).
measure: Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Treatment-emergent Serious Adverse Events (TESAEs)
time frame: Day 1 through Day 1130 (maximum observed duration)
description: An adverse event (AE) is any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. An SAE is defined as an AE that meets one of the following criteria: requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions, is a congenital anomaly/birth defect, is medically important, results in death, or is life-threatening. In this trial, a TEAE was defined as an AE occurring or worsening between the first dose of enapotamab vedotin and 30 days after the last dose received.
measure: Number of Participants With Treatment-emergent Infusion-related AEs and TEAEs Related to Enapotamab Vedotin
time frame: Day 1 through Day 1130 (maximum observed duration)
description: Number of participants with treatment-emergent infusion-related AEs and TEAEs related to enapotamab vedotin is reported.
measure: Number of Participants With >= Grade 3 TEAEs as Assessed by National Cancer Institute - Common Terminology Criteria for Adverse Events (NCI-CTCAE) Version 4.03
time frame: Day 1 through Day 1130 (maximum observed duration)
description: Number of participants with TEAEs of >= Grade 3 as assessed by NCI-CTCAE v4.03 is reported. The NCI-CTCAE is a descriptive terminology is used for AE reporting. The NCI-CTCAE v4.03 displays Grades 1 through 5 with unique clinical descriptions of severity for each AE, based on this general guideline: Grade 1 as mild AE, Grade 2 as moderate AE, Grade 3 as severe AE, Grade 4 as life-threatening or disabling AE, and Grade 5 as death. If a participant reported multiple severity grades for an AE, only the maximum grade was used.
measure: Number of Participants With Grade 3 or 4 Laboratory Results
time frame: Day 1 through Day 1130 (maximum observed duration)
description: Number of participants with laboratory measurements graded as Grade 3 or 4 by NCI-CTCAE v 4.03 is reported.
measure: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity (AUC0-inf) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part
time frame: Predose, end of infusion (EOI), and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3
description: The AUC0-inf of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.
measure: Area Under the Plasma Concentration-time Curve From Time 0 to Last Measurable Concentration (AUC0-last) of Conjugated Enapotamab Vedotin for 1Q3W Dose-escalation Part
time frame: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3
description: The AUC0-last of conjugated enapotamab vedotin for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.
measure: Maximum Observed Plasma Concentration (Cmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose and EOI on Days 1 and 8 of Cycles 1 and 3; and predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The Cmax of conjugated enapotamab vedotin for dose-escalation part is reported.
measure: Total Clearance (CL) of Conjugated Enapotamab Vedotin in Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The total CL of conjugated enapotamab vedotin in dose-escalation part is reported.
measure: Time of Maximum Plasma Concentration (Tmax) of Conjugated Enapotamab Vedotin for Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The Tmax of conjugated enapotamab vedotin for dose-escalation part is reported.
measure: Half-life Lambda-z (t1/2) of Conjugated Enapotamab Vedotin for Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The t1/2 of conjugated enapotamab vedotin for dose-escalation part is reported.
measure: Volume of Distribution at Steady State (Vss) of Conjugated Enapotamab Vedotin for Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The Vss of conjugated enapotamab vedotin for dose-escalation part is reported.
measure: AUC0-inf of Free Toxin Monomethyl Auristatin E (MMAE) for 1Q3W Dose-escalation Part
time frame: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3
description: The AUC0-inf of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.
measure: AUC0-last of MMAE for 1Q3W Dose-escalation Part
time frame: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3
description: The AUC0-last of MMAE for 1Q3W dose-escalation part is reported. Sample scheduling of the 3Q4W dosing regimen did not allow calculation of the specific outcome measure.
measure: Cmax of MMAE for Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose and EOI on Days 1 and 8 of Cycles 1 and 3; and predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The Cmax of MMAE for dose-escalation part is reported.
measure: Total CL of MMAE in Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The total CL of MMAE in dose-escalation part is reported.
measure: Tmax of MMAE for Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The Tmax of MMAE for dose-escalation part is reported.
measure: t1/2 of MMAE for Dose-escalation Part
time frame: For 1Q3W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 1 of Cycles 1 and 3; For 3Q4W dosing regimen: Predose, EOI, and 2 and 5 hours after EOI on Day 15 of Cycles 1 and 3
description: The t1/2 of MMAE for dose-escalation part is reported.
measure: Number of Participants With Antidrug Antibodies (ADAs) Confirmed Positive to Enapotamab Vedotin
time frame: Day 1 through Day 1130 (Dose-escalation part: Predose of Day 1 of Cycles 1 to 12, end of treatment [EOT], and 30 days after last study drug; Expansion part: Predose on Day 1 of Cycles 1 to 5, then every fourth cycle until PD)
description: The ADA assessment was performed according to a tiered approach. First samples were screened for an ADA response; positively screened samples were analyzed in a confirmation method. Subsequently confirmed positive samples were analyzed for titre and the presence of neutralizing antibodies. Number of participants with ADA confirmed positive to enapotamab vedotin is reported.
measure: Number of Participants With Objective Response (OR) Based on Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) As Assessed by Investigator
time frame: Day 1 through 44.5 months (maximum observed duration)
description: Radiological evaluation based on RECIST v1.1 was performed by the investigator using computed tomography (CT) scans/ magnetic resonance imaging (MRI) scans/ positron emission tomography (PET) scans. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to < 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD.
measure: Number of Participants With Best Cancer Antigen 125 (CA-125) Response
time frame: From Screening (within 2 weeks before starting of the study treatment) through Day 1130 (maximum observed duration)
description: The best CA-125 response was evaluated in participants with ovarian cancer. A CA-125 partial response was defined as at least a 50% reduction in CA-125 levels in blood from a pretreatment sample. Participants who had a CA-125 partial response and had CA-125 level falls to within the reference range (0-35 units/mL) were classified as CA-125 complete responders. The response was confirmed and maintained for at least 28 days. The best overall response (CA-125 partial response and CA-125 complete response) is reported.
measure: Duration of Response (DoR) Based on RECIST v1.1 as Assessed by Investigator for Expansion Part
time frame: Day 1 through 44.5 months (maximum observed duration)
description: The DoR was defined as the number of months from the first documentation of objective tumor response (CR or PR) to the date of first progressive disease (PD) or death. The OR was defined as confirmed CR or confirmed PR per RECIST v1.1. The changes in tumor measurements that were confirmed by repeat assessments performed no less than 4 weeks after initial response are called confirmed responses. The CR was defined as disappearance of all target and non-target lesions and all pathological lymph nodes must have decreased to < 10 mm in short axis. The PR was defined as at least a 30% decrease in the sum of the longest diameters (LD) of target lesions taking as reference the baseline sum of LD. The PD was defined as at least 20% increase in the sum of LD of target lesions taking as reference the smallest sum of the LD recorded since the treatment started or the appearance of one or more new target and non-target lesions and/or unequivocal progression of existing non-target lesions.
measure: Progression Free Survival (PFS) as Assessed by Investigator
time frame: Day 1 through 44.5 months (maximum observed duration)
description: The PFS was defined as the number of months from the date of first study drug administration to first PD or death. The PD was defined as at least 20% increase in the sum of longest diameters of target lesions taking as reference the smallest sum of the longest diameters recorded since the treatment started or the appearance of one or more new lesions. The PFS was estimated using Kaplan-Meier method.
measure: Overall Survival (OS)
time frame: Day 1 through 44.5 months (maximum observed duration)
description: Overall survival was defined as the number of months from date of first study drug administration to death. The OS was estimated using Kaplan-Meier method.
measure: Change in AXL Expression (Total Tumor H-score) From Baseline to EOT Visit for Expansion Part
time frame: Baseline (Study Days -21 to 1) and EOT visit (Day 1100)
description: Change in AXL expression (total humor H-score in membrane or cytoplasm) from Baseline to EOT visit for the expansion part is reported. The H-score captures both the intensity and proportion of AXL positive tumor cells and was defined by the formula: H-score = (1 × % 1+ tumor cells) + (2 × % 2+ tumor cells) + (3 × % 3+ tumor cells); where '1+' indicates weak staining intensity, '2+' indicates medium staining intensity, and '3+' indicates strong staining intensity. The H-score values ranges from 0 to 300. Lower H-scores represent lower AXL expression in the tumor sample, while higher scores represent stronger AXL expression in the tumor samples.
arm group label: Enapotamab vedotin (HuMax-AXL-ADC)
arm group type: Experimental
description: Participants in all cohorts of the trial (both in escalation and expansion phase) will be administered enapotamab vedotin (HuMax-AXL-ADC) intravenously (IV).
intervention type: Biological
intervention name: Enapotamab vedotin (HuMax-AXL-ADC)
description: Enapotamab vedotin (HuMax-AXL-ADC) will be administered intravenously.
arm group label: Enapotamab vedotin (HuMax-AXL-ADC)
criteria: 
gender: All
minimum age: 18 Years
maximum age: N/A
healthy volunteers: No
last name: Ignace Vergote, Professor
role: Principal Investigator
affiliation: Universitair Ziekenhuizen Leuven
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
facility: 
country: Belgium
country: Denmark
country: Netherlands
country: Spain
country: United Kingdom
country: United States
responsible party type: Sponsor
mesh term: Endometrial Neoplasms
provided document: 
provided document: 
participant flow: 
baseline: 
outcome list: 
reported events: 
certain agreements: 
limitations and caveats: No participants with castration-resistant prostate cancer were enrolled, hence no prostate-specific antigen (PSA) data were available and pre-specified outcome measure related to PSA data are not reported.
point of contact: 